titration.
References
1. Bjørkøy, G. et al., J. Cell. Biol., 171, 603-614
(2005).
2. Ralston, S.H. et al., Lancet, 372, 155-163 (2008).
3. Pankiv, S. et al., J. Biol. Chem., 282, 24131-24145
(2007
titration.
References
1. Bjørkøy, G. et al., J. Cell. Biol., 171, 603-614
(2005).
2. Ralston, S.H. et al., Lancet, 372, 155-163 (2008).
3. Pankiv, S. et al., J. Biol. Chem., 282, 24131-24145
(2007
mode of inhibitory action by
aphidicolin on eukaryotic DNA polymerase alpha.
Eur. J. Biochem., 97, 603-607 (1979).
12. Ikegami, S. et al., Aphidicolin prevents mitotic cell
division by interfering with
typical according to manufacturer.
R.D. Gonz !alez et al. / Food Microbiology 20 (2003) 601–604 603
isolates with b-d-glucuronidase positive reaction. A
higher value (99%) was observed by
typical according to manufacturer.
R.D. Gonz !alez et al. / Food Microbiology 20 (2003) 601–604 603
isolates with b-d-glucuronidase positive reaction. A
higher value (99%) was observed by
antipermeability and anti-inflammatory agent in
vitro and targets cell junctions. Circulation Research 87:603-607.
13
17. Bates DO et al. (2002) Regulation of microvascular permeability by vascular
antipermeability and anti-inflammatory
agent in vitro and targets cell junctions. Circulation Research 87:603-607.
17. Bates DO et al. (2002) Regulation of microvascular permeability by vascular
endothelial
antipermeability and anti-inflammatory agent in
vitro and targets cell junctions. Circulation Research 87:603-607.
13
17. Bates DO et al. (2002) Regulation of microvascular permeability by vascular
RNase A (10 mg/mL) and incubate 30 minutes at 37°C.
2. Add 1 µL Proteinase K and incubate at 62°C for 2 hours.
3. Load 10 µL and 20 µL on a 1-2% agarose gel with a 100 bp DNA
an antipermeability and anti-inflammatory agent in vitro and
targets cell junctions. Circ. Res. 87:603-607.
16. Bates DO et al. (2002) Regulation of microvascular permeability by vascular endothelial
from Mice. Infection and Immunity 66:603-607.
Dahl, J., A. Jurczak, L. A. Cheng, D. C. Baker, and T. L. Benjamin. (1998)
Evidence of a Role for Phosphatidylinositol 3-Kinase Activation in the Blocking
PRMT5 P0493 10419 PRMT5 M NP_001034708.1 y y y
707 TAP T1076 10482 NXF1 M NP_001074960.1 y n/d n/d
603 PRMT4 P4995 10498 CARM1 P NP_954592.1 y n/d n/d
250 Endothelial Cell Protein C Receptor E6280 10544
PRMT5 P0493 10419 PRMT5 M NP_001034708.1 y y y
707 TAP T1076 10482 NXF1 M NP_001074960.1 y n/d n/d
603 PRMT4 P4995 10498 CARM1 P NP_954592.1 y n/d n/d
250 Endothelial Cell Protein C Receptor E6280 10544
PRMT5 P0493 10419 PRMT5 M NP_001034708.1 y y y
707 TAP T1076 10482 NXF1 M NP_001074960.1 y n/d n/d
603 PRMT4 P4995 10498 CARM1 P NP_954592.1 y n/d n/d
250 Endothelial Cell Protein C Receptor E6280 10544
P6996 P y y y
600 Anti Cy3+Cy5 C0992 M NA NA NA
601 PRMT2 P0748 M y n/d n/d
602 PRMT3 P9370 M y y y
603 PRMT4 P4995 P y n/d n/d
604 PRMT5 P0493 M y y y
605 PRMT6 P6495 P y
Armand, M. Nature 2001, 414, 359–367.
(2) Goodenough, J. B.; Kim, Y. Chem. Mater. 2010, 22, 583–603.
(3) Hou, H. D.; Gan, B. H.; Gong, Y. D.; Chen, N.; Sun, C. W. Inorg.
Chem. 2016, 55, 9033–9037.